Pharma Focus Asia

TiumBio and Hansoh Pharma Announce Clinical Trial Approval of HS-10518/TU2670

Thursday, July 06, 2023

TiumBio and Hansoh Pharmaceutical Group announced that the China National Medical Products Administration (NMPA) has granted approval for Hansoh's Investigational New Drug (IND) application for the clinical study of HS-10518, also known as TU2670. 

The focus of the study is to evaluate the potential of HS-10518 in managing moderate to severe pain associated with endometriosis.

TU2670, also referred to as HS-10518, is a promising investigational non-peptide gonadotropin-releasing hormone (GnRH) antagonist that can be taken orally. It is being developed as a potential treatment for endometriosis and uterine fibroids. This drug aims to provide enhanced convenience in terms of dosing and exhibits a superior safety profile when compared to current treatment options.

Endometriosis is a condition where the endometrial tissue, which normally lines the inside of the uterus, grows outside the uterus. It can cause various symptoms such as severe pelvic pain, menstrual pain, lower abdominal pain, and infertility. It affects approximately 11 percent of women of childbearing age, and it is estimated that there are about 18 million patients with endometriosis in Europe.

The IND approval from the NMPA paves the way for further clinical studies of TU2670 in China. This approval represents a significant step forward in the field of endometriosis treatment, offering hope for improved options and better outcomes for patients in China.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024